Invacare Corp. (NYSE: IVC) reported Q4 EPS of ($0.12), $0.15 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $318.2 million versus the consensus estimate of $310.4 million.

Commenting on the financial results for the fourth quarter and year ended December 31, 2014, Robert K. Gudbranson, Interim President and Chief Executive Officer, stated, ''In the fourth quarter, the team successfully managed working capital to achieve free cash flow(a) of $11.4 million, which led to free cash flow(a) of $8.4 million for the full year. The Company further reduced total debt outstanding to $22.3 million as of December 31, 2014. As was the case throughout 2014, the European business segment finished the year with another strong quarter. Additionally, the IPG business segment, excluding intangible impairment charges, and the Asia/Pacific segment both increased earnings before income taxes compared to the fourth quarter of 2013. For the fourth quarter of 2014, adjusted net loss per share(b) improved to $0.12 compared to an adjusted net loss per share(b) of $0.22 in the fourth quarter of 2013.''

Gudbranson continued, ''While the Company is not giving guidance, it is important to mention that if the Euro continues to be weak compared to prior year, it may negatively impact our 2015 performance, as the European segment was our main driver of profitability and cash flow in 2014. Accordingly, we will monitor and manage cash flow particularly closely. The Company also will work diligently toward improving the profitability of our North America/HME and Asia/Pacific businesses and continuing our quality systems remediation.''

For earnings history and earnings-related data on Invacare Corp. (IVC) click here.